Tepha, Inc. – Trademark Portfolio

Entity Type: 03

Tepha, Inc. holds 21 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 13 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 3 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include TEPHA, TEPHAFLEX, and TEPHELAST. The owner is based in Lexington, MA.

Suite 360

99 Hayden Avenue East Wing

Lexington, MA 02421

21 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Tepha, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (13 filings)

Surgical, medical, dental and veterinary apparatus and instruments

1
Chemicals (8 filings)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Tepha, Inc. have?

Tepha, Inc. has 21 U.S. trademarks filed with the USPTO. Of these, 4 registered, 17 abandoned.

What trademark classes does Tepha, Inc. file in?

Tepha, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 1 (Chemicals), Class 5 (Pharmaceuticals). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Tepha, Inc.'s most well-known trademarks?

Tepha, Inc.'s registered trademark portfolio includes well-known marks such as TEPHA, TEPHAFLEX, and TEPHELAST. These are among 4 currently registered trademarks in the portfolio.

What is Tepha, Inc.'s trademark registration success rate?

Tepha, Inc. has a 19% trademark registration rate, with 4 out of 21 resolved applications resulting in successful registration. Currently, 0 applications are pending review.